Pelletier, Jean-Pierre
Martel-Pelletier, Johanne
Funding for this research was provided by:
European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Article History
Received: 14 December 2017
Accepted: 8 February 2018
First Online: 21 February 2018
Compliance with ethical standards
:
: Professor Jean-Pierre Pelletier is a shareholder in ArthroLab Inc. and received grants, consulting and lecture fees from TRB Chemedica. He also served as expert witness for the review of diacerein-containing medicines by the European Medicine Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC). Professor Johanne Martel-Pelletier is a shareholder in ArthroLab Inc., and received grants, consulting, and lecture fees from TRB Chemedica. She also served as expert witness for the review of diacerein-containing medicines by the European Medicine Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC).
: None.
: None.